These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 8903655

  • 1. Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
    Halimi JM, Mimran A.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1801-2. PubMed ID: 8903655
    [Abstract] [Full Text] [Related]

  • 2. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
    Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
    [Abstract] [Full Text] [Related]

  • 3. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
    Maule S, Mulatero P, Milan A, Leotta G, Caserta M, Bertello C, Rabbia F, Veglio F.
    J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L, Fardella C, Montero J, Rojas P, Sánchez O, Rojas V, Rojas A, Huete A, Soto J, Foradori A.
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [Abstract] [Full Text] [Related]

  • 6. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M, Catena C, Nadalini E, Colussi GL, Baroselli S, Chiuch A, Lapenna R, Bazzocchi M, Sechi LA.
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [Abstract] [Full Text] [Related]

  • 7. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C.
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A, Postuła M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M, Janas J, Janaszek-Sitkowska H, Makowiecka-Cieśla M, Januszkiewicz A.
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [Abstract] [Full Text] [Related]

  • 10. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS.
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [Abstract] [Full Text] [Related]

  • 11. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J.
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [Abstract] [Full Text] [Related]

  • 12. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
    Médeau V, Moreau F, Trinquart L, Clemessy M, Wémeau JL, Vantyghem MC, Plouin PF, Reznik Y.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
    [Abstract] [Full Text] [Related]

  • 13. The diagnosis of primary aldosteronism and separation of two major subtypes.
    Weinberger MH, Fineberg NS.
    Arch Intern Med; 1993 Sep 27; 153(18):2125-9. PubMed ID: 8379804
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of insulin in hypertension with high and low levels of renin].
    Sindelka G, Widimský J, Prázný M, Kasalová Z, Skrha J.
    Cas Lek Cesk; 2001 Apr 12; 140(7):205-8. PubMed ID: 11374224
    [Abstract] [Full Text] [Related]

  • 16. Primary aldosteronism in diabetic subjects with resistant hypertension.
    Umpierrez GE, Cantey P, Smiley D, Palacio A, Temponi D, Luster K, Chapman A.
    Diabetes Care; 2007 Jul 12; 30(7):1699-703. PubMed ID: 17429062
    [Abstract] [Full Text] [Related]

  • 17. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K, Fujii K, Oniki H, Oka M, Iida M.
    Am J Hypertens; 2006 Jan 12; 19(1):13-8. PubMed ID: 16461184
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA.
    Arch Intern Med; 2008 Jan 14; 168(1):80-5. PubMed ID: 18195199
    [Abstract] [Full Text] [Related]

  • 19. Adiponectin and insulin sensitivity in primary aldosteronism.
    Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R, Veglio F, Mulatero P.
    Am J Hypertens; 2007 Aug 14; 20(8):855-61. PubMed ID: 17679033
    [Abstract] [Full Text] [Related]

  • 20. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M, Bachmann AW, Jonsson JR, Tunny TJ, Klemm SA, Gordon RD.
    J Hypertens; 1995 Dec 14; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.